Global Short Bowel Syndrome(SBS) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 86

Published Date: 01 Jan 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Short Bowel Syndrome(SBS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Short Bowel Syndrome(SBS) market size is estimated to be worth US$ 895.2 million in 2021 and is forecast to a readjusted size of USD 3837 million by 2028 with a CAGR of 23.1% during review period. Hospitals accounting for  % of the Short Bowel Syndrome(SBS) global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Oral Route segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Short Bowel Syndrome(SBS) include Merck, Takeda, Emmaus Medical, Ardelyx, and Naia Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Short Bowel Syndrome(SBS) market is split by Type and by Sale Channel. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Sale Channel. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral Route
    Parental Route

Market segment by Sale Channel, can be divided into
    Hospitals
    Clinics
    Retail Pharmacies

Market segment by players, this report covers
    Merck
    Takeda
    Emmaus Medical
    Ardelyx
    Naia Pharmaceuticals
    Nutrinia
    OxThera
    Sancilio Pharmaceuticals
    Zealand Pharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Short Bowel Syndrome(SBS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Short Bowel Syndrome(SBS), with revenue, gross margin and global market share of Short Bowel Syndrome(SBS) from 2019 to 2022.
Chapter 3, the Short Bowel Syndrome(SBS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Short Bowel Syndrome(SBS) market forecast, by regions, type and sale channel, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Short Bowel Syndrome(SBS) research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Short Bowel Syndrome(SBS)
    1.2 Classification of Short Bowel Syndrome(SBS) by Type
        1.2.1 Overview: Global Short Bowel Syndrome(SBS) Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Short Bowel Syndrome(SBS) Revenue Market Share by Type in 2021
        1.2.3 Oral Route
        1.2.4 Parental Route
    1.3 Global Short Bowel Syndrome(SBS) Market by Sale Channel
        1.3.1 Overview: Global Short Bowel Syndrome(SBS) Market Size by Sale Channel: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Retail Pharmacies
    1.4 Global Short Bowel Syndrome(SBS) Market Size & Forecast
    1.5 Global Short Bowel Syndrome(SBS) Market Size and Forecast by Region
        1.5.1 Global Short Bowel Syndrome(SBS) Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Short Bowel Syndrome(SBS) Market Size by Region, (2017-2022)
        1.5.3 North America Short Bowel Syndrome(SBS) Market Size and Prospect (2017-2028)
        1.5.4 Europe Short Bowel Syndrome(SBS) Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Short Bowel Syndrome(SBS) Market Size and Prospect (2017-2028)
        1.5.6 South America Short Bowel Syndrome(SBS) Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Short Bowel Syndrome(SBS) Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Short Bowel Syndrome(SBS) Market Drivers
        1.6.2 Short Bowel Syndrome(SBS) Market Restraints
        1.6.3 Short Bowel Syndrome(SBS) Trends Analysis

2 Company Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck Short Bowel Syndrome(SBS) Product and Solutions
        2.1.4 Merck Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Merck Recent Developments and Future Plans
    2.2 Takeda
        2.2.1 Takeda Details
        2.2.2 Takeda Major Business
        2.2.3 Takeda Short Bowel Syndrome(SBS) Product and Solutions
        2.2.4 Takeda Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Takeda Recent Developments and Future Plans
    2.3 Emmaus Medical
        2.3.1 Emmaus Medical Details
        2.3.2 Emmaus Medical Major Business
        2.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Product and Solutions
        2.3.4 Emmaus Medical Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Emmaus Medical Recent Developments and Future Plans
    2.4 Ardelyx
        2.4.1 Ardelyx Details
        2.4.2 Ardelyx Major Business
        2.4.3 Ardelyx Short Bowel Syndrome(SBS) Product and Solutions
        2.4.4 Ardelyx Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Ardelyx Recent Developments and Future Plans
    2.5 Naia Pharmaceuticals
        2.5.1 Naia Pharmaceuticals Details
        2.5.2 Naia Pharmaceuticals Major Business
        2.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Product and Solutions
        2.5.4 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Naia Pharmaceuticals Recent Developments and Future Plans
    2.6 Nutrinia
        2.6.1 Nutrinia Details
        2.6.2 Nutrinia Major Business
        2.6.3 Nutrinia Short Bowel Syndrome(SBS) Product and Solutions
        2.6.4 Nutrinia Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Nutrinia Recent Developments and Future Plans
    2.7 OxThera
        2.7.1 OxThera Details
        2.7.2 OxThera Major Business
        2.7.3 OxThera Short Bowel Syndrome(SBS) Product and Solutions
        2.7.4 OxThera Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 OxThera Recent Developments and Future Plans
    2.8 Sancilio Pharmaceuticals
        2.8.1 Sancilio Pharmaceuticals Details
        2.8.2 Sancilio Pharmaceuticals Major Business
        2.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Product and Solutions
        2.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Sancilio Pharmaceuticals Recent Developments and Future Plans
    2.9 Zealand Pharma
        2.9.1 Zealand Pharma Details
        2.9.2 Zealand Pharma Major Business
        2.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Product and Solutions
        2.9.4 Zealand Pharma Short Bowel Syndrome(SBS) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Zealand Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Short Bowel Syndrome(SBS) Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Short Bowel Syndrome(SBS) Players Market Share in 2021
        3.2.2 Top 10 Short Bowel Syndrome(SBS) Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Short Bowel Syndrome(SBS) Players Head Office, Products and Services Provided
    3.4 Short Bowel Syndrome(SBS) Mergers & Acquisitions
    3.5 Short Bowel Syndrome(SBS) New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Short Bowel Syndrome(SBS) Revenue and Market Share by Type (2017-2022)
    4.2 Global Short Bowel Syndrome(SBS) Market Forecast by Type (2023-2028)

5 Market Size Segment by Sale Channel
    5.1 Global Short Bowel Syndrome(SBS) Revenue Market Share by Sale Channel (2017-2022)
    5.2 Global Short Bowel Syndrome(SBS) Market Forecast by Sale Channel (2023-2028)

6 North America by Country, by Type, and by Sale Channel
    6.1 North America Short Bowel Syndrome(SBS) Revenue by Type (2017-2028)
    6.2 North America Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2028)
    6.3 North America Short Bowel Syndrome(SBS) Market Size by Country
        6.3.1 North America Short Bowel Syndrome(SBS) Revenue by Country (2017-2028)
        6.3.2 United States Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        6.3.3 Canada Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        6.3.4 Mexico Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Sale Channel
    7.1 Europe Short Bowel Syndrome(SBS) Revenue by Type (2017-2028)
    7.2 Europe Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2028)
    7.3 Europe Short Bowel Syndrome(SBS) Market Size by Country
        7.3.1 Europe Short Bowel Syndrome(SBS) Revenue by Country (2017-2028)
        7.3.2 Germany Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        7.3.3 France Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        7.3.5 Russia Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        7.3.6 Italy Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Sale Channel
    8.1 Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Type (2017-2028)
    8.2 Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2028)
    8.3 Asia-Pacific Short Bowel Syndrome(SBS) Market Size by Region
        8.3.1 Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Region (2017-2028)
        8.3.2 China Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        8.3.3 Japan Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        8.3.4 South Korea Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        8.3.5 India Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        8.3.7 Australia Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Sale Channel
    9.1 South America Short Bowel Syndrome(SBS) Revenue by Type (2017-2028)
    9.2 South America Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2028)
    9.3 South America Short Bowel Syndrome(SBS) Market Size by Country
        9.3.1 South America Short Bowel Syndrome(SBS) Revenue by Country (2017-2028)
        9.3.2 Brazil Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        9.3.3 Argentina Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Sale Channel
    10.1 Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Type (2017-2028)
    10.2 Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2028)
    10.3 Middle East & Africa Short Bowel Syndrome(SBS) Market Size by Country
        10.3.1 Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Country (2017-2028)
        10.3.2 Turkey Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)
        10.3.4 UAE Short Bowel Syndrome(SBS) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Short Bowel Syndrome(SBS) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Short Bowel Syndrome(SBS) Revenue by Sale Channel, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Short Bowel Syndrome(SBS) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Short Bowel Syndrome(SBS) Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Short Bowel Syndrome(SBS) Revenue Market Share by Region (2023-2028)
    Table 6. Merck Corporate Information, Head Office, and Major Competitors
    Table 7. Merck Major Business
    Table 8. Merck Short Bowel Syndrome(SBS) Product and Solutions
    Table 9. Merck Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Takeda Corporate Information, Head Office, and Major Competitors
    Table 11. Takeda Major Business
    Table 12. Takeda Short Bowel Syndrome(SBS) Product and Solutions
    Table 13. Takeda Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Emmaus Medical Corporate Information, Head Office, and Major Competitors
    Table 15. Emmaus Medical Major Business
    Table 16. Emmaus Medical Short Bowel Syndrome(SBS) Product and Solutions
    Table 17. Emmaus Medical Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Ardelyx Corporate Information, Head Office, and Major Competitors
    Table 19. Ardelyx Major Business
    Table 20. Ardelyx Short Bowel Syndrome(SBS) Product and Solutions
    Table 21. Ardelyx Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Naia Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 23. Naia Pharmaceuticals Major Business
    Table 24. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Product and Solutions
    Table 25. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Nutrinia Corporate Information, Head Office, and Major Competitors
    Table 27. Nutrinia Major Business
    Table 28. Nutrinia Short Bowel Syndrome(SBS) Product and Solutions
    Table 29. Nutrinia Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. OxThera Corporate Information, Head Office, and Major Competitors
    Table 31. OxThera Major Business
    Table 32. OxThera Short Bowel Syndrome(SBS) Product and Solutions
    Table 33. OxThera Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Sancilio Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 35. Sancilio Pharmaceuticals Major Business
    Table 36. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Product and Solutions
    Table 37. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Zealand Pharma Corporate Information, Head Office, and Major Competitors
    Table 39. Zealand Pharma Major Business
    Table 40. Zealand Pharma Short Bowel Syndrome(SBS) Product and Solutions
    Table 41. Zealand Pharma Short Bowel Syndrome(SBS) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Global Short Bowel Syndrome(SBS) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 43. Global Short Bowel Syndrome(SBS) Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 44. Breakdown of Short Bowel Syndrome(SBS) by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Short Bowel Syndrome(SBS) Players Head Office, Products and Services Provided
    Table 46. Short Bowel Syndrome(SBS) Mergers & Acquisitions in the Past Five Years
    Table 47. Short Bowel Syndrome(SBS) New Entrants and Expansion Plans
    Table 48. Global Short Bowel Syndrome(SBS) Revenue (USD Million) by Type (2017-2022)
    Table 49. Global Short Bowel Syndrome(SBS) Revenue Share by Type (2017-2022)
    Table 50. Global Short Bowel Syndrome(SBS) Revenue Forecast by Type (2023-2028)
    Table 51. Global Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2022)
    Table 52. Global Short Bowel Syndrome(SBS) Revenue Forecast by Sale Channel (2023-2028)
    Table 53. North America Short Bowel Syndrome(SBS) Revenue by Type (2017-2022) & (USD Million)
    Table 54. North America Short Bowel Syndrome(SBS) Revenue by Type (2023-2028) & (USD Million)
    Table 55. North America Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2022) & (USD Million)
    Table 56. North America Short Bowel Syndrome(SBS) Revenue by Sale Channel (2023-2028) & (USD Million)
    Table 57. North America Short Bowel Syndrome(SBS) Revenue by Country (2017-2022) & (USD Million)
    Table 58. North America Short Bowel Syndrome(SBS) Revenue by Country (2023-2028) & (USD Million)
    Table 59. Europe Short Bowel Syndrome(SBS) Revenue by Type (2017-2022) & (USD Million)
    Table 60. Europe Short Bowel Syndrome(SBS) Revenue by Type (2023-2028) & (USD Million)
    Table 61. Europe Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2022) & (USD Million)
    Table 62. Europe Short Bowel Syndrome(SBS) Revenue by Sale Channel (2023-2028) & (USD Million)
    Table 63. Europe Short Bowel Syndrome(SBS) Revenue by Country (2017-2022) & (USD Million)
    Table 64. Europe Short Bowel Syndrome(SBS) Revenue by Country (2023-2028) & (USD Million)
    Table 65. Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Type (2017-2022) & (USD Million)
    Table 66. Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Type (2023-2028) & (USD Million)
    Table 67. Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2022) & (USD Million)
    Table 68. Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Sale Channel (2023-2028) & (USD Million)
    Table 69. Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Region (2017-2022) & (USD Million)
    Table 70. Asia-Pacific Short Bowel Syndrome(SBS) Revenue by Region (2023-2028) & (USD Million)
    Table 71. South America Short Bowel Syndrome(SBS) Revenue by Type (2017-2022) & (USD Million)
    Table 72. South America Short Bowel Syndrome(SBS) Revenue by Type (2023-2028) & (USD Million)
    Table 73. South America Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2022) & (USD Million)
    Table 74. South America Short Bowel Syndrome(SBS) Revenue by Sale Channel (2023-2028) & (USD Million)
    Table 75. South America Short Bowel Syndrome(SBS) Revenue by Country (2017-2022) & (USD Million)
    Table 76. South America Short Bowel Syndrome(SBS) Revenue by Country (2023-2028) & (USD Million)
    Table 77. Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Type (2017-2022) & (USD Million)
    Table 78. Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Type (2023-2028) & (USD Million)
    Table 79. Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Sale Channel (2017-2022) & (USD Million)
    Table 80. Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Sale Channel (2023-2028) & (USD Million)
    Table 81. Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Country (2017-2022) & (USD Million)
    Table 82. Middle East & Africa Short Bowel Syndrome(SBS) Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Short Bowel Syndrome(SBS) Picture
    Figure 2. Global Short Bowel Syndrome(SBS) Revenue Market Share by Type in 2021
    Figure 3. Oral Route
    Figure 4. Parental Route
    Figure 5. Short Bowel Syndrome(SBS) Revenue Market Share by Sale Channel in 2021
    Figure 6. Hospitals Picture
    Figure 7. Clinics Picture
    Figure 8. Retail Pharmacies Picture
    Figure 9. Global Short Bowel Syndrome(SBS) Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 10. Global Short Bowel Syndrome(SBS) Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Short Bowel Syndrome(SBS) Revenue Market Share by Region (2017-2028)
    Figure 12. Global Short Bowel Syndrome(SBS) Revenue Market Share by Region in 2021
    Figure 13. North America Short Bowel Syndrome(SBS) Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 14. Europe Short Bowel Syndrome(SBS) Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 15. Asia-Pacific Short Bowel Syndrome(SBS) Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. South America Short Bowel Syndrome(SBS) Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Middle East and Africa Short Bowel Syndrome(SBS) Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Short Bowel Syndrome(SBS) Market Drivers
    Figure 19. Short Bowel Syndrome(SBS) Market Restraints
    Figure 20. Short Bowel Syndrome(SBS) Market Trends
    Figure 21. Merck Recent Developments and Future Plans
    Figure 22. Takeda Recent Developments and Future Plans
    Figure 23. Emmaus Medical Recent Developments and Future Plans
    Figure 24. Ardelyx Recent Developments and Future Plans
    Figure 25. Naia Pharmaceuticals Recent Developments and Future Plans
    Figure 26. Nutrinia Recent Developments and Future Plans
    Figure 27. OxThera Recent Developments and Future Plans
    Figure 28. Sancilio Pharmaceuticals Recent Developments and Future Plans
    Figure 29. Zealand Pharma Recent Developments and Future Plans
    Figure 30. Global Short Bowel Syndrome(SBS) Revenue Share by Players in 2021
    Figure 31. Short Bowel Syndrome(SBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 32. Global Top 3 Players Short Bowel Syndrome(SBS) Revenue Market Share in 2021
    Figure 33. Global Top 10 Players Short Bowel Syndrome(SBS) Revenue Market Share in 2021
    Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 35. Global Short Bowel Syndrome(SBS) Revenue Share by Type in 2021
    Figure 36. Global Short Bowel Syndrome(SBS) Market Share Forecast by Type (2023-2028)
    Figure 37. Global Short Bowel Syndrome(SBS) Revenue Share by Sale Channel in 2021
    Figure 38. Global Short Bowel Syndrome(SBS) Market Share Forecast by Sale Channel (2023-2028)
    Figure 39. North America Short Bowel Syndrome(SBS) Sales Market Share by Type (2017-2028)
    Figure 40. North America Short Bowel Syndrome(SBS) Sales Market Share by Sale Channel (2017-2028)
    Figure 41. North America Short Bowel Syndrome(SBS) Revenue Market Share by Country (2017-2028)
    Figure 42. United States Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Canada Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Mexico Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Europe Short Bowel Syndrome(SBS) Sales Market Share by Type (2017-2028)
    Figure 46. Europe Short Bowel Syndrome(SBS) Sales Market Share by Sale Channel (2017-2028)
    Figure 47. Europe Short Bowel Syndrome(SBS) Revenue Market Share by Country (2017-2028)
    Figure 48. Germany Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. France Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. United Kingdom Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Russia Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Italy Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Asia-Pacific Short Bowel Syndrome(SBS) Sales Market Share by Type (2017-2028)
    Figure 54. Asia-Pacific Short Bowel Syndrome(SBS) Sales Market Share by Sale Channel (2017-2028)
    Figure 55. Asia-Pacific Short Bowel Syndrome(SBS) Revenue Market Share by Region (2017-2028)
    Figure 56. China Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. South Korea Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Short Bowel Syndrome(SBS) Sales Market Share by Type (2017-2028)
    Figure 63. South America Short Bowel Syndrome(SBS) Sales Market Share by Sale Channel (2017-2028)
    Figure 64. South America Short Bowel Syndrome(SBS) Revenue Market Share by Country (2017-2028)
    Figure 65. Brazil Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Argentina Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Middle East and Africa Short Bowel Syndrome(SBS) Sales Market Share by Type (2017-2028)
    Figure 68. Middle East and Africa Short Bowel Syndrome(SBS) Sales Market Share by Sale Channel (2017-2028)
    Figure 69. Middle East and Africa Short Bowel Syndrome(SBS) Revenue Market Share by Country (2017-2028)
    Figure 70. Turkey Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Saudi Arabia Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. UAE Short Bowel Syndrome(SBS) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Product Tags

short bowel syndrome sbs

short bowel syndrome sbs drugs

Short Bowel Syndrome (SBS)

Short Bowel Syndrome (SBS) Drugs

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>